MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 08.08.2025
89bio P/E 2011-2026 | ETNB
P/E Jährlich 89bio
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.66 | -6.35 | -4.33 | -1.31 | -0.961 | -1.24 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.961 | -6.35 | -2.81 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-2.15 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.183 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
5.53 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
16.3 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-0.0167 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-18.5 | - | 0.74 % | $ 768 M |  Israel |
|
Galera Therapeutics
GRTX
|
-0.403 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-251 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
-24.7 | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-121 | $ 35.0 | 1.6 % | $ 942 M | USA |
|
Forte Biosciences
FBRX
|
-4.83 | $ 22.0 | 8.32 % | $ 285 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-0.259 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
-1.41 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.18 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
-19.4 | $ 90.93 | 0.63 % | $ 22 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.65 | 1.85 % | $ 439 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
21.2 | $ 8.11 | -0.98 % | $ 5.51 B |  Spain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
0.00975 | - | -4.36 % | $ 27 M | USA |
 |
Heron Therapeutics
HRTX
|
-9.92 | $ 0.87 | 3.09 % | $ 145 M | USA |
 |
Compugen Ltd.
CGEN
|
5.55 | $ 2.61 | -3.51 % | $ 244 M | Israel |
 |
Anika Therapeutics
ANIK
|
-19.7 | $ 15.02 | -0.79 % | $ 215 M | USA |
 |
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-0.964 | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
15.1 | $ 97.41 | 0.34 % | $ 19 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
-56.3 | $ 75.78 | 0.96 % | $ 12.1 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.735 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 3.44 | -0.58 % | $ 5.66 M | Israel |
 |
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
1.35 | $ 1.57 | 3.97 % | $ 184 M | USA |
 |
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-213 | $ 21.01 | 2.64 % | $ 2.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | USA |